Ying Li1,2, Tao Zhang2,3, Tianshu Han1, Shengxu Li3, Lydia Bazzano3, Jiang He3, Wei Chen3. 1. Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin, China. 2. Department of Biostatistics, School of Public Health, Shandong University, Jinan, China. 3. Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.
Abstract
OBJECTIVES: Despite the inverse association between cigarette smoking and body mass index (BMI), it is unknown whether the effect of smoking on insulin is mediated through decreased BMI. This study aims to examine the temporal relationship between BMI and insulin, the impact of smoking on this relationship and the mediation effect of BMI on the association between smoking and insulin levels. METHODS: The longitudinal cohort consisted of 1121 adults (807 white and 314 black participants, mean age, 42.0 years at follow-up) for whom BMI and fasting insulin were measured twice, with an average follow-up period of 17.1 years. Cross-lagged panel and mediation analysis models were used to examine the temporal relationship between BMI and insulin, and the mediation effect of BMI on the smoking-insulin association. RESULTS: Smoking was inversely associated with insulin (regression coefficient, -0.073; P = .015 at baseline and -0.121; P < .001 at follow-up), adjusting for age, race and gender. After additional adjustment for follow-up periods, the cross-lagged path coefficient from BMI to insulin (β, 0.226; P < .001) was significantly greater than that from insulin to BMI (β, -0.029; P = .208), with P < .001 for the difference. The path coefficient from BMI to insulin was significantly greater in non-smokers (β, 0.273; P < .001) than in smokers (β, 0.122; P = .046), with P = .013 for the difference. The mediation effect of BMI on the smoking-insulin association was estimated at 53.4% (P = .030) at baseline and 58.7% (P < .001) at follow-up. CONCLUSIONS: These findings suggest that cigarette smoking has a significant impact on the one-directional relationship from BMI to insulin. The insulin-lowering effect of smoking is predominantly mediated through decreased BMI as the result of smoking.
OBJECTIVES: Despite the inverse association between cigarette smoking and body mass index (BMI), it is unknown whether the effect of smoking on insulin is mediated through decreased BMI. This study aims to examine the temporal relationship between BMI and insulin, the impact of smoking on this relationship and the mediation effect of BMI on the association between smoking and insulin levels. METHODS: The longitudinal cohort consisted of 1121 adults (807 white and 314 black participants, mean age, 42.0 years at follow-up) for whom BMI and fasting insulin were measured twice, with an average follow-up period of 17.1 years. Cross-lagged panel and mediation analysis models were used to examine the temporal relationship between BMI and insulin, and the mediation effect of BMI on the smoking-insulin association. RESULTS: Smoking was inversely associated with insulin (regression coefficient, -0.073; P = .015 at baseline and -0.121; P < .001 at follow-up), adjusting for age, race and gender. After additional adjustment for follow-up periods, the cross-lagged path coefficient from BMI to insulin (β, 0.226; P < .001) was significantly greater than that from insulin to BMI (β, -0.029; P = .208), with P < .001 for the difference. The path coefficient from BMI to insulin was significantly greater in non-smokers (β, 0.273; P < .001) than in smokers (β, 0.122; P = .046), with P = .013 for the difference. The mediation effect of BMI on the smoking-insulin association was estimated at 53.4% (P = .030) at baseline and 58.7% (P < .001) at follow-up. CONCLUSIONS: These findings suggest that cigarette smoking has a significant impact on the one-directional relationship from BMI to insulin. The insulin-lowering effect of smoking is predominantly mediated through decreased BMI as the result of smoking.
Authors: Vassilios G Athyros; Niki Katsiki; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis Journal: Curr Med Res Opin Date: 2013-08-08 Impact factor: 2.580
Authors: Ewan C McNay; Jennifer A Teske; Catherine M Kotz; Ambrose Dunn-Meynell; Barry E Levin; Rory J McCrimmon; Robert S Sherwin Journal: Am J Physiol Endocrinol Metab Date: 2012-11-20 Impact factor: 4.310
Authors: Jaana Keto; Hanna Ventola; Jari Jokelainen; Kari Linden; Sirkka Keinänen-Kiukaanniemi; Markku Timonen; Tero Ylisaukko-Oja; Juha Auvinen Journal: Open Heart Date: 2016-07-12
Authors: Anatoly N Varaksin; Ekaterina D Konstantinova; Tatiana A Maslakova; Yulia V Shalaumova; Galia M Nasybullina Journal: Children (Basel) Date: 2022-02-07
Authors: Judith J M Rijnhart; Sophia J Lamp; Matthew J Valente; David P MacKinnon; Jos W R Twisk; Martijn W Heymans Journal: BMC Med Res Methodol Date: 2021-10-25 Impact factor: 4.615
Authors: Yanxu Yang; Yendelela L Cuffee; Betsy B Aumiller; Kathryn Schmitz; David M Almeida; Vernon M Chinchilli Journal: Front Psychol Date: 2022-02-21